FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/REGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Regeneron Pharmaceuticals Inc (REGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $902.29, down 3.05% with strong fundamentals including 85.77% gross margins and consistent earnings beats. The stock shows bullish technical signals despite overbought RSI readings, supported by recent positive clinical trial data and a major $8 billion immunology alliance expansion with Sanofi. Revenue growth remains solid with 2025 revenue of $14.34 billion and net income of $4.50 billion.
Outlook remains positive with analyst consensus at Buy (69% of 49 analysts) and $887.79 price target. Key opportunities include pipeline expansion and immunology partnership, while risks involve competitive pressures in ophthalmology and clinical trial execution. The company maintains strong cash flow generation with $634.70M net cash flow in 2025.
Read full analysis

Key Stats

  • Market Cap
    $93.40B
  • Volume
    1,398,322
  • Sector
    Health
  • 52W High
    $973.36
  • 52W Low
    $600.66
  • Typical Hold Time
    108 Days
  • Enterprise Value
    $86.81B
  • Div Yield
    0.42%
  • Trading Activity
    49% Sell | 51% Buy
$900.07
52W Low: $600.66
01 Jun 2026
52W High: $973.36
03 Nov 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $600.66 and a high of $973.36, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Most Recent News

Content is generated by Aura AI

Medical imaging workstations market to double by 2036, driven by AI and cloud tech growth

The global medical imaging workstations market is projected to grow from USD 6.20 billion in 2026 to USD 12.55 billion by 2036, at a CAGR of 7.3%. Growth is fueled by rising chronic disease prevalence, increased diagnostic imaging demand, and advance...

Market News
13 minutes ago
Researchandmarkets.Com
Bullish
news icon
Medical imaging workstations market to double by 2036, driven by AI and cloud tech growth

Global sacral neuromodulation market to grow at 11.1% CAGR, reaching $3.92B by 2036 driven by tech advances and aging population

The global sacral neuromodulation market is projected to grow from $1.37 billion in 2026 to $3.92 billion by 2036, at an 11.1% CAGR. Growth is fueled by rising cases of urinary and fecal incontinence, demand for minimally invasive treatments, and an ...

Market News
14 minutes ago
Researchandmarkets.Com
Bullish
news icon
Global sacral neuromodulation market to grow at 11.1% CAGR, reaching $3.92B by 2036 driven by tech advances and aging population

Mexico's animal healthcare market to grow to $3.34B by 2031, driven by pets, livestock, and diagnostics.

The Mexico animal healthcare market is projected to grow from $2.13 billion in 2025 to $3.34 billion by 2031, at a CAGR of 7.84%. Growth is fueled by rising spending on companion animals, expanding livestock production, and innovations in veterinary ...

Market News
1 hour ago
Researchandmarkets.Com
Bullish
news icon
Mexico's animal healthcare market to grow to $3.34B by 2031, driven by pets, livestock, and diagnostics.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $93.40B
  • Volume
    1,398,322
  • Sector
    Health
  • 52W High
    $973.36
  • 52W Low
    $600.66
  • Typical Hold Time
    108 Days
  • Enterprise Value
    $86.81B
  • Div Yield
    0.42%
  • Trading Activity
    49% Sell | 51% Buy
$900.07
52W Low: $600.66
01 Jun 2026
52W High: $973.36
03 Nov 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $600.66 and a high of $973.36, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!